Reports

Industry Research Reports

Home > Reports > Service & Software > Plasma Fractionation Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Plasma Fractionation Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Plasma Fractionation Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-03-06

Pages: 131 Pages

Report ld: 6028393

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Plasma Fractionation Technology Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

7.5%

marketSize

Market Size,2032

USD 62,130

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 40,260 million
Market Forecast in 2032(Value)
US$ 62,130 million
CAGR
7.5%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Plasma Fractionation Technology was estimated to be worth US$ 37710 million in 2025 and is projected to reach US$ 62130 million, growing at a CAGR of 7.5% from 2026 to 2032.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.

Market Drivers:

Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.

Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.

Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.

Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.

Market Challenges:

High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.

Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.

Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.

Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.

The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.

The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.

North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.

This report provides a comprehensive view of the global market for Plasma Fractionation Technology, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Plasma Fractionation Technology market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Plasma Fractionation Technology.

MARKET SEGMENTATION

By Company

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

marn_i1

Chapter 2: Provides a detailed analysis of the Plasma Fractionation Technology companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

marn_i1

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Presents Plasma Fractionation Technology revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

marn_i1

Chapter 6: Presents Plasma Fractionation Technology revenue at the country level. It provides segmented data by Type and by Application for each country/region.

marn_i1

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

marn_i1

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Plasma Fractionation Technology Product Introduction

1.2 Global Plasma Fractionation Technology Market Size Forecast (2021–2032)

1.3 Plasma Fractionation Technology Market Trends & Drivers

1.3.1 Plasma Fractionation Technology Industry Trends

1.3.2 Plasma Fractionation Technology Market Drivers & Opportunities

1.3.3 Plasma Fractionation Technology Market Challenges

1.3.4 Plasma Fractionation Technology Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Plasma Fractionation Technology Players Revenue Ranking (2025)

2.2 Global Plasma Fractionation Technology Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Plasma Fractionation Technology Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Plasma Fractionation Technology

2.6 Plasma Fractionation Technology Market Competitive Analysis

2.6.1 Plasma Fractionation Technology Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Plasma Fractionation Technology Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Plasma Fractionation Technology revenue, 2025

2.7 Mergers & Acquisitions and Expansion

muLu

3 Segmentation Plasma Fractionation Technology Market Classification

3.1 Introduction by Type

3.1.1 Immune Globulin

3.1.2 Coagulation Factor

3.1.3 Albumin

3.1.4 Other

3.1.5 Global Plasma Fractionation Technology Sales Value by Type

3.1.5.1 Global Plasma Fractionation Technology Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Plasma Fractionation Technology Sales Value, by Type (2021–2032)

3.1.5.3 Global Plasma Fractionation Technology Sales Value, by Type (%), 2021–2032

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Retail Pharmacy

4.1.3 Other

4.2 Global Plasma Fractionation Technology Sales Value by Application

4.2.1 Global Plasma Fractionation Technology Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Plasma Fractionation Technology Sales Value by Application (2021–2032)

4.2.3 Global Plasma Fractionation Technology Sales Value by Application (%), 2021–2032

muLu

5 Segmentation by Region

5.1 Global Plasma Fractionation Technology Sales Value by Region

5.1.1 Global Plasma Fractionation Technology Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Plasma Fractionation Technology Sales Value by Region (2021–2026)

5.1.3 Global Plasma Fractionation Technology Sales Value by Region (2027–2032)

5.1.4 Global Plasma Fractionation Technology Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Plasma Fractionation Technology Sales Value, 2021–2032

5.2.2 North America Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Plasma Fractionation Technology Sales Value, 2021–2032

5.3.2 Europe Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Plasma Fractionation Technology Sales Value, 2021–2032

5.4.2 Asia Pacific Plasma Fractionation Technology Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Plasma Fractionation Technology Sales Value, 2021–2032

5.5.2 South America Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Plasma Fractionation Technology Sales Value, 2021–2032

5.6.2 Middle East & Africa Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Plasma Fractionation Technology Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Plasma Fractionation Technology Sales Value, 2021–2032

6.3 United States

6.3.1 United States Plasma Fractionation Technology Sales Value, 2021–2032

6.3.2 United States Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Plasma Fractionation Technology Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Plasma Fractionation Technology Sales Value, 2021–2032

6.4.2 Europe Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Plasma Fractionation Technology Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Plasma Fractionation Technology Sales Value, 2021–2032

6.5.2 China Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032

6.5.3 China Plasma Fractionation Technology Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Plasma Fractionation Technology Sales Value, 2021–2032

6.6.2 Japan Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Plasma Fractionation Technology Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Plasma Fractionation Technology Sales Value, 2021–2032

6.7.2 South Korea Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Plasma Fractionation Technology Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Plasma Fractionation Technology Sales Value, 2021–2032

6.8.2 Southeast Asia Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Plasma Fractionation Technology Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Plasma Fractionation Technology Sales Value, 2021–2032

6.9.2 India Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032

6.9.3 India Plasma Fractionation Technology Sales Value by Application, 2025 vs 2032

muLu

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Profile

7.1.2 Takeda Main Business

7.1.3 Takeda Plasma Fractionation Technology Products, Services, and Solutions

7.1.4 Takeda Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.1.5 Takeda Recent Developments

7.2 CSL

7.2.1 CSL Profile

7.2.2 CSL Main Business

7.2.3 CSL Plasma Fractionation Technology Products, Services, and Solutions

7.2.4 CSL Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.2.5 CSL Recent Developments

7.3 Grifols

7.3.1 Grifols Profile

7.3.2 Grifols Main Business

7.3.3 Grifols Plasma Fractionation Technology Products, Services, and Solutions

7.3.4 Grifols Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.3.5 Grifols Recent Developments

7.4 Octapharma

7.4.1 Octapharma Profile

7.4.2 Octapharma Main Business

7.4.3 Octapharma Plasma Fractionation Technology Products, Services, and Solutions

7.4.4 Octapharma Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.4.5 Octapharma Recent Developments

7.5 Kedrion

7.5.1 Kedrion Profile

7.5.2 Kedrion Main Business

7.5.3 Kedrion Plasma Fractionation Technology Products, Services, and Solutions

7.5.4 Kedrion Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.5.5 Kedrion Recent Developments

7.6 LFB Group

7.6.1 LFB Group Profile

7.6.2 LFB Group Main Business

7.6.3 LFB Group Plasma Fractionation Technology Products, Services, and Solutions

7.6.4 LFB Group Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.6.5 LFB Group Recent Developments

7.7 Biotest

7.7.1 Biotest Profile

7.7.2 Biotest Main Business

7.7.3 Biotest Plasma Fractionation Technology Products, Services, and Solutions

7.7.4 Biotest Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.7.5 Biotest Recent Developments

7.8 BPL

7.8.1 BPL Profile

7.8.2 BPL Main Business

7.8.3 BPL Plasma Fractionation Technology Products, Services, and Solutions

7.8.4 BPL Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.8.5 BPL Recent Developments

7.9 RAAS

7.9.1 RAAS Profile

7.9.2 RAAS Main Business

7.9.3 RAAS Plasma Fractionation Technology Products, Services, and Solutions

7.9.4 RAAS Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.9.5 RAAS Recent Developments

7.10 CBPO

7.10.1 CBPO Profile

7.10.2 CBPO Main Business

7.10.3 CBPO Plasma Fractionation Technology Products, Services, and Solutions

7.10.4 CBPO Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.10.5 CBPO Recent Developments

7.11 Hualan Bio

7.11.1 Hualan Bio Profile

7.11.2 Hualan Bio Main Business

7.11.3 Hualan Bio Plasma Fractionation Technology Products, Services, and Solutions

7.11.4 Hualan Bio Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.11.5 Hualan Bio Recent Developments

7.12 Tiantan Bio

7.12.1 Tiantan Bio Profile

7.12.2 Tiantan Bio Main Business

7.12.3 Tiantan Bio Plasma Fractionation Technology Products, Services, and Solutions

7.12.4 Tiantan Bio Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.12.5 Tiantan Bio Recent Developments

7.13 Shuanglin Bio

7.13.1 Shuanglin Bio Profile

7.13.2 Shuanglin Bio Main Business

7.13.3 Shuanglin Bio Plasma Fractionation Technology Products, Services, and Solutions

7.13.4 Shuanglin Bio Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.13.5 Shuanglin Bio Recent Developments

7.14 Boya Bio

7.14.1 Boya Bio Profile

7.14.2 Boya Bio Main Business

7.14.3 Boya Bio Plasma Fractionation Technology Products, Services, and Solutions

7.14.4 Boya Bio Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.14.5 Boya Bio Recent Developments

7.15 Yuanda Shuyang

7.15.1 Yuanda Shuyang Profile

7.15.2 Yuanda Shuyang Main Business

7.15.3 Yuanda Shuyang Plasma Fractionation Technology Products, Services, and Solutions

7.15.4 Yuanda Shuyang Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.15.5 Yuanda Shuyang Recent Developments

7.16 Weiguang Bio

7.16.1 Weiguang Bio Profile

7.16.2 Weiguang Bio Main Business

7.16.3 Weiguang Bio Plasma Fractionation Technology Products, Services, and Solutions

7.16.4 Weiguang Bio Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.16.5 Weiguang Bio Recent Developments

7.17 Nanyue Bio

7.17.1 Nanyue Bio Profile

7.17.2 Nanyue Bio Main Business

7.17.3 Nanyue Bio Plasma Fractionation Technology Products, Services, and Solutions

7.17.4 Nanyue Bio Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.17.5 Nanyue Bio Recent Developments

7.18 KM Biologics

7.18.1 KM Biologics Profile

7.18.2 KM Biologics Main Business

7.18.3 KM Biologics Plasma Fractionation Technology Products, Services, and Solutions

7.18.4 KM Biologics Plasma Fractionation Technology Revenue (US$ Million), 2021–2026

7.18.5 KM Biologics Recent Developments

muLu

8 Industry Chain Analysis

8.1 Plasma Fractionation Technology Value Chain

8.2 Plasma Fractionation Technology Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Plasma Fractionation Technology Sales Model

8.5.2 Sales Channels

8.5.3 Plasma Fractionation Technology Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Plasma Fractionation Technology Market Trends
Table 2. Plasma Fractionation Technology Market Drivers & Opportunities
Table 3. Plasma Fractionation Technology Market Challenges
Table 4. Plasma Fractionation Technology Market Restraints
Table 5. Global Plasma Fractionation Technology Revenue by Company (US$ Million), 2021–2026
Table 6. Global Plasma Fractionation Technology Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Plasma Fractionation Technology Product Type
Table 9. Key Companies General Availability (GA) Timeline for Plasma Fractionation Technology
Table 10. Global Plasma Fractionation Technology Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Plasma Fractionation Technology revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Plasma Fractionation Technology Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Plasma Fractionation Technology Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Plasma Fractionation Technology Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Plasma Fractionation Technology Sales Market Share in Value by Type (2021–2026)
Table 17. Global Plasma Fractionation Technology Sales Market Share in Value by Type (2027–2032)
Table 18. Global Plasma Fractionation Technology Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Plasma Fractionation Technology Sales Value by Application (US$ Million), 2021–2026
Table 20. Global Plasma Fractionation Technology Sales Value by Application (US$ Million), 2027–2032
Table 21. Global Plasma Fractionation Technology Sales Market Share in Value by Application (2021–2026)
Table 22. Global Plasma Fractionation Technology Sales Market Share in Value by Application (2027–2032)
Table 23. Global Plasma Fractionation Technology Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global Plasma Fractionation Technology Sales Value by Region (US$ Million), 2021–2026
Table 25. Global Plasma Fractionation Technology Sales Value by Region (US$ Million), 2027–2032
Table 26. Global Plasma Fractionation Technology Sales Value by Region (%), 2021–2026
Table 27. Global Plasma Fractionation Technology Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions Plasma Fractionation Technology Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions Plasma Fractionation Technology Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions Plasma Fractionation Technology Sales Value, (US$ Million), 2027–2032
Table 31. Takeda Basic Information List
Table 32. Takeda Description and Business Overview
Table 33. Takeda Plasma Fractionation Technology Products, Services, and Solutions
Table 34. Revenue (US$ Million) in Plasma Fractionation Technology Business of Takeda (2021–2026)
Table 35. Takeda Recent Developments
Table 36. CSL Basic Information List
Table 37. CSL Description and Business Overview
Table 38. CSL Plasma Fractionation Technology Products, Services, and Solutions
Table 39. Revenue (US$ Million) in Plasma Fractionation Technology Business of CSL (2021–2026)
Table 40. CSL Recent Developments
Table 41. Grifols Basic Information List
Table 42. Grifols Description and Business Overview
Table 43. Grifols Plasma Fractionation Technology Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Plasma Fractionation Technology Business of Grifols (2021–2026)
Table 45. Grifols Recent Developments
Table 46. Octapharma Basic Information List
Table 47. Octapharma Description and Business Overview
Table 48. Octapharma Plasma Fractionation Technology Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Plasma Fractionation Technology Business of Octapharma (2021–2026)
Table 50. Octapharma Recent Developments
Table 51. Kedrion Basic Information List
Table 52. Kedrion Description and Business Overview
Table 53. Kedrion Plasma Fractionation Technology Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Plasma Fractionation Technology Business of Kedrion (2021–2026)
Table 55. Kedrion Recent Developments
Table 56. LFB Group Basic Information List
Table 57. LFB Group Description and Business Overview
Table 58. LFB Group Plasma Fractionation Technology Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Plasma Fractionation Technology Business of LFB Group (2021–2026)
Table 60. LFB Group Recent Developments
Table 61. Biotest Basic Information List
Table 62. Biotest Description and Business Overview
Table 63. Biotest Plasma Fractionation Technology Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Plasma Fractionation Technology Business of Biotest (2021–2026)
Table 65. Biotest Recent Developments
Table 66. BPL Basic Information List
Table 67. BPL Description and Business Overview
Table 68. BPL Plasma Fractionation Technology Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Plasma Fractionation Technology Business of BPL (2021–2026)
Table 70. BPL Recent Developments
Table 71. RAAS Basic Information List
Table 72. RAAS Description and Business Overview
Table 73. RAAS Plasma Fractionation Technology Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Plasma Fractionation Technology Business of RAAS (2021–2026)
Table 75. RAAS Recent Developments
Table 76. CBPO Basic Information List
Table 77. CBPO Description and Business Overview
Table 78. CBPO Plasma Fractionation Technology Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Plasma Fractionation Technology Business of CBPO (2021–2026)
Table 80. CBPO Recent Developments
Table 81. Hualan Bio Basic Information List
Table 82. Hualan Bio Description and Business Overview
Table 83. Hualan Bio Plasma Fractionation Technology Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Plasma Fractionation Technology Business of Hualan Bio (2021–2026)
Table 85. Hualan Bio Recent Developments
Table 86. Tiantan Bio Basic Information List
Table 87. Tiantan Bio Description and Business Overview
Table 88. Tiantan Bio Plasma Fractionation Technology Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Plasma Fractionation Technology Business of Tiantan Bio (2021–2026)
Table 90. Tiantan Bio Recent Developments
Table 91. Shuanglin Bio Basic Information List
Table 92. Shuanglin Bio Description and Business Overview
Table 93. Shuanglin Bio Plasma Fractionation Technology Products, Services, and Solutions
Table 94. Revenue (US$ Million) in Plasma Fractionation Technology Business of Shuanglin Bio (2021–2026)
Table 95. Shuanglin Bio Recent Developments
Table 96. Boya Bio Basic Information List
Table 97. Boya Bio Description and Business Overview
Table 98. Boya Bio Plasma Fractionation Technology Products, Services, and Solutions
Table 99. Revenue (US$ Million) in Plasma Fractionation Technology Business of Boya Bio (2021–2026)
Table 100. Boya Bio Recent Developments
Table 101. Yuanda Shuyang Basic Information List
Table 102. Yuanda Shuyang Description and Business Overview
Table 103. Yuanda Shuyang Plasma Fractionation Technology Products, Services, and Solutions
Table 104. Revenue (US$ Million) in Plasma Fractionation Technology Business of Yuanda Shuyang (2021–2026)
Table 105. Yuanda Shuyang Recent Developments
Table 106. Weiguang Bio Basic Information List
Table 107. Weiguang Bio Description and Business Overview
Table 108. Weiguang Bio Plasma Fractionation Technology Products, Services, and Solutions
Table 109. Revenue (US$ Million) in Plasma Fractionation Technology Business of Weiguang Bio (2021–2026)
Table 110. Weiguang Bio Recent Developments
Table 111. Nanyue Bio Basic Information List
Table 112. Nanyue Bio Description and Business Overview
Table 113. Nanyue Bio Plasma Fractionation Technology Products, Services, and Solutions
Table 114. Revenue (US$ Million) in Plasma Fractionation Technology Business of Nanyue Bio (2021–2026)
Table 115. Nanyue Bio Recent Developments
Table 116. KM Biologics Basic Information List
Table 117. KM Biologics Description and Business Overview
Table 118. KM Biologics Plasma Fractionation Technology Products, Services, and Solutions
Table 119. Revenue (US$ Million) in Plasma Fractionation Technology Business of KM Biologics (2021–2026)
Table 120. KM Biologics Recent Developments
Table 121. Revenue (US$ Million) in Plasma Fractionation Technology Business of Company 40 (2021–2026)
Table 122. Company 40 Recent Developments
Table 123. Key Raw Materials Lists
Table 124. Key Suppliers of Raw Materials Lists
Table 125. Plasma Fractionation Technology Downstream Customers
Table 126. Plasma Fractionation Technology Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Plasma Fractionation Technology Product Picture
Figure 2. Global Plasma Fractionation Technology Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 4. Plasma Fractionation Technology Report Years Considered
Figure 5. Global Plasma Fractionation Technology Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Plasma Fractionation Technology Revenue in 2025
Figure 7. Plasma Fractionation Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Immune Globulin Picture
Figure 9. Coagulation Factor Picture
Figure 10. Albumin Picture
Figure 11. Other Picture
Figure 12. Global Plasma Fractionation Technology Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Plasma Fractionation Technology Sales Value Market Share by Type, 2025 & 2032
Figure 14. Product Picture of Hospital
Figure 15. Product Picture of Retail Pharmacy
Figure 16. Product Picture of Other
Figure 17. Global Plasma Fractionation Technology Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Plasma Fractionation Technology Sales Value Market Share by Application, 2025 & 2032
Figure 19. North America Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 20. North America Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032
Figure 21. Europe Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 22. Europe Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032
Figure 23. Asia Pacific Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 24. Asia Pacific Plasma Fractionation Technology Sales Value by Subregion (%), 2025 vs 2032
Figure 25. South America Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 26. South America Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032
Figure 27. Middle East & Africa Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 28. Middle East & Africa Plasma Fractionation Technology Sales Value by Country (%), 2025 vs 2032
Figure 29. Key Countries/Regions Plasma Fractionation Technology Sales Value (%), 2021–2032
Figure 30. United States Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 31. United States Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032
Figure 32. United States Plasma Fractionation Technology Sales Value by Application (%), 2025 vs 2032
Figure 33. Europe Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 34. Europe Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032
Figure 35. Europe Plasma Fractionation Technology Sales Value by Application (%), 2025 vs 2032
Figure 36. China Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 37. China Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032
Figure 38. China Plasma Fractionation Technology Sales Value by Application (%), 2025 vs 2032
Figure 39. Japan Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 40. Japan Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032
Figure 41. Japan Plasma Fractionation Technology Sales Value by Application (%), 2025 vs 2032
Figure 42. South Korea Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 43. South Korea Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032
Figure 44. South Korea Plasma Fractionation Technology Sales Value by Application (%), 2025 vs 2032
Figure 45. Southeast Asia Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 46. Southeast Asia Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032
Figure 47. Southeast Asia Plasma Fractionation Technology Sales Value by Application (%), 2025 vs 2032
Figure 48. India Plasma Fractionation Technology Sales Value (US$ Million), 2021–2032
Figure 49. India Plasma Fractionation Technology Sales Value by Type (%), 2025 vs 2032
Figure 50. India Plasma Fractionation Technology Sales Value by Application (%), 2025 vs 2032
Figure 51. Plasma Fractionation Technology Value Chain
Figure 52. Plasma Fractionation Technology Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Plasma Fractionation Technology in 2032?zhanKai
The global market size of Plasma Fractionation Technology in 2032 was 62130 Million USD.
What is the annual compound growth rate of the global Plasma Fractionation Technology market size from 2026 to 2032?shouQi
Which companies rank high in the global Plasma Fractionation Technology market?shouQi
What was the global market size of Plasma Fractionation Technology in 2026?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Plasma Fractionation Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-03-06

Pages: 131 Pages

Report ld: 6028393

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Online

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Offline

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Offline

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now